Boyle A. Uniform addition of ribavirin to sofosbuvir/velpatasvir for genotype 3 patients with cirrhosis: real world outcomes. THU-285.
WHO introduceert de ‘Toolkit for research and development of paediatric antiretroviral drugs and formulations’
sep 2019 | HIV